Discovery of Substituted Maleimides as Liver X Receptor Agonists and Determination of a Ligand-Bound Crystal Structure
- 1 August 2005
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 48 (17), 5419-5422
- https://doi.org/10.1021/jm050532w
Abstract
Substituted 3-(phenylamino)-1H-pyrrole-2,5-diones were identified from a high throughput screen as inducers of human ATP binding cassette transporter A1 expression. Mechanism of action studies led to the identification of GSK3987 (4) as an LXR ligand. 4 recruits the steroid receptor coactivator-1 to human LXRα and LXRβ with EC50s of 40 nM, profiles as an LXR agonist in functional assays, and activates LXR though a mechanism that is similar to first generation LXR agonists.Keywords
This publication has 12 references indexed in Scilit:
- Macrophage Liver X Receptor Is Required for Antiatherogenic Activity of LXR AgonistsArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Crystal Structure of the Human Liver X Receptor β Ligand-binding Domain in Complex with a Synthetic AgonistJournal of Molecular Biology, 2003
- The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouseJournal of Lipid Research, 2003
- Crystal structure of the heterodimeric complex of LXR and RXR ligand-binding domains in a fully agonistic conformationThe EMBO Journal, 2003
- Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissueProceedings of the National Academy of Sciences, 2003
- Liver X Receptor Activators Display Anti-Inflammatory Activity in Irritant and Allergic Contact Dermatitis Models: Liver-X-Receptor-Specific Inhibition of Inflammation and Primary Cytokine ProductionJournal of Investigative Dermatology, 2003
- Reciprocal regulation of inflammation and lipid metabolism by liver X receptorsNature Medicine, 2003
- Novel Roles of Liver X Receptors Exposed by Gene Expression Profiling in Liver and Adipose TissueMolecular Pharmacology, 2002
- T‐0901317, a synthetic liver X receptor ligand, inhibits development of atherosclerosis in LDL receptor‐deficient miceFEBS Letters, 2002
- Role of LXRs in control of lipogenesisGenes & Development, 2000